Legal Representation
Attorney
Victoria D. Summerfield
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 4, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 4, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jun 24, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 24, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 24, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 23, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 23, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 23, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 17, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 3, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 2, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 31, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Mar 31, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 31, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 31, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Detailed Classifications
Class 005
Technological drug delivery platforms, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of therapeutic pharmaceutical molecules through various tissue structures to optimize absorption in the skin, eyes, hair, bones, teeth and mucosal surfaces of humans and animals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical molecules through various tissue structures for use in the cosmetic and veterinary medicine industries; pharmaceutical drug delivery agents consisting of compounds that facilitate topical delivery of a wide range of therapeutic pharmaceutical agents; pharmaceutical preparations for the treatment of skin, eye, hair, bone, tooth and mucosal disorders and conditions; dermatological pharmaceutical products; ocular pharmaceuticals; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in humans and animals
First Use Anywhere:
Jun 8, 2018
First Use in Commerce:
Nov 2, 2018
Additional Information
Design Mark
The mark consists of A stylized teardrop over the words Illustris Pharmaceuticals, Inc. with a stylized i for the word Illustris.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005